Physician profile
Michelle Lee Cisneros
NPI 1285609842
$618.46
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.32 · 2020: $41.70 · 2021: $66.70 · 2022: $303 · 2023: $102 · 2024: $22.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $140.03 | 2022 | |
| Abbvie INC. | $129.42 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $124.24 | 2019-2023 | |
| Alcon Vision LLC | $85.08 | 2020-2022 | |
| Shire North American Group INC | $40.74 | 2019 | |
| Horizon Therapeutics Plc | $27.92 | 2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $24.13 | 2019 | |
| Oyster Point Pharma, INC. | $24.01 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $22.89 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Cisneros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.